Amgen’s Ian Thompson On Payer Shifts, Obesity Opportunity And The Future Of Blockbusters

Launches Have Longer Ramp-Up In High-Pressure Markets

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.